Two New Ebola Outbreaks
Democratic Republic of Congo and Guinea
Just a few months after declaring the end of the last outbreak in the Democratic Republic of Congo (DRC), they have confirmed four new cases of Ebola. On February 7th the Minister of Health of the Democratic Republic of the Congo declared an outbreak of Ebola (WHO). An Ebola vaccination campaign has begun in Butembo, in eastern DRC, according to the WHO.
Separately, the West African country of Guinea declared a new Ebola outbreak on February 14th, with seven confirmed cases and three deaths. This is the first time the disease has been reported in Guinea since the 2013-2016 outbreak in West Africa; the largest Ebola outbreak in history, which claimed over 11,000 lives. “It’s a huge concern to see the resurgence of Ebola in Guinea, a country which has already suffered so much from the disease”, said Matshidiso Moeti, WHO Regional Director for Africa.
Get updates on the N’Zerekore, Guinea outbreak and the North Kivu, Democratic Republic of the Congo outbreak at the WHO. As of March 31st 2021, 12 Ebola cases have been reported in D.R. Congo and 18 cases have been reported in Guinea (Africa CDC).
Support for both regions is being mobilized by the World Health Organization and partner organizations. The U.S. government is funneling travelers from Guinea and the DRC to six U.S. airports and collecting passenger information for CDC public health follow-up (CDC).
The Advisory Committee on Immunization Practices (ACIP) recommended pre-exposure prophylaxis vaccination with rVSV-ZEBOV for adults ≥ 18 years of age in the U.S. population who are at potential occupational risk of exposure to Zaire ebolavirus. This includes adults who are esponding or planning to respond to an outbreak of EVD; laboratorians or other staff working at biosafety-level 4 facilities that work with live Ebola virus in the United States; or healthcare personnel working at federally designated U.S. Ebola Treatment Centers (CDC). Adults who fall into these categories can find more information on the Ebola vaccine at the CDC page on expanded access to the Investigational New Drug (IND) program.
The National Emerging Special Pathogens Training and Education Center (NETEC) was stood up in the wake of the 2013-16 Ebola Epidemic, which highlighted the need for rapid response and dissemination of information during an outbreak. NETEC remains prepared to support the global response to Ebola.
Specific for the current situation, NETEC has collected some essential Ebola-related resources on this page. Additionally, healthcare and public health professionals can submit a question to one of NETEC’s many experts via the web portal or by emailing email@example.com.